Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/Sinovac Biotech, Ltd./ 20-F

SEC Filing · 20-F

Sinovac Biotech, Ltd.

SVANASDAQEQUITYCurrent

SEC Filing

Filed Apr 29, 2024Accepted Apr 29, 2024, 4:30 PM EDTCIK 1084201Accession 0000950170-24-049936
View company →Permanent SEC source ↗
Share

Company context

Current securities

SVANASDAQ · EQUITY · Current

Recent company filings

  1. 6-K filingAug 17, 2026
  2. 6-K filingJul 15, 2026
  3. 6-K filingJun 15, 2026
  4. 6-K filingJun 5, 2026
  5. 20-F filingJun 5, 2026

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗